Commercial-stage biotech TG Therapeutics (NASDAQ: TGTX) was having a fine week on the stock exchange, thanks in no small part ...

TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript May 2, 2024 TG Therapeutics, Inc. isn't one of the 30 ...

TG Therapeutics beat first quarter revenue expectations and raised the full-year revenue guidance by $40 million at the ...

TG Therapeutics, Inc. (NASDAQ:TGTX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus statutory numbers for both ...

TG Therapeutics (TGTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Alec ...

In a report released today, Corinne Johnson from Goldman Sachs maintained a Hold rating on TG Therapeutics (TGTX – Research Report), with ...

Antoine Dufresne-Fortin agreed, and even highlighted a wider societal issue: “Buttons are the way to go. Easier to use and less distracting. We look at our phone screen all day long, so I don't feel ...

TG Bharat, TDP candidate, vowed to create 20 lakh jobs, ensure comprehensive Kurnool city assembly constituency development, ...

By Sabela Ojea Shares of TG Therapeutics on Wednesday jumped after the company reported first-quarter revenue in the first quarter. The stock was up 27% ...

TG Bharat criticizes YSRCP for underdevelopment, promises growth through TDP & NDA alliance. Focus on investments, tackling ...

Jenna Bosco; Senior Vice President, Corporate Communications; TG Therapeutics Inc Michael Weiss; Chairman, President, and Chief Executive Officer; TG Therapeutics Inc Adam Waldman; Chief ...

TG Therapeutics missed on the bottom line, but investors were more cheered by the top-line development. TG Therapeutics' nearly $50.5 million in first-quarter product revenue derived entirely from ...